Skip to main content
  • More from ADA
    • Diabetes
    • Diabetes Care
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Clinical Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Browse
    • Issue Archive
    • Saved Searches
    • COVID-19 Article Collection
    • Quality Improvement Sucess Stories
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
    • Clinical Compendia
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
  • Advertising
  • Reprints/Reuse
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • Instructions for Authors
    • ADA Journal Policies
  • More from ADA
    • Diabetes
    • Diabetes Care
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Browse
    • Issue Archive
    • Saved Searches
    • COVID-19 Article Collection
    • Quality Improvement Sucess Stories
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
    • Clinical Compendia
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
  • Advertising
  • Reprints/Reuse
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • Instructions for Authors
    • ADA Journal Policies
Features

The Science of Diabetic Snack Bars: A Review

  1. Lisa E. Rafkin-Mervis, MS, RD, CDE and
  2. Jennifer B. Marks, MD, CDE
    Clinical Diabetes 2001 Jan; 19(1): 4-12. https://doi.org/10.2337/diaclin.19.1.4
    PreviousNext
    • Article
    • Figures & Tables
    • Info & Metrics
    • PDF
    Loading

    Article Figures & Tables

    Figures

    • Tables
    • Figure 1.
      • Download figure
      • Open in new tab
      • Download powerpoint
      Figure 1.

      Incidence of hypoglycemic events in the cornstarch (CS) group compared to the standard snack (SS) group. Adapted from Kaufman et al.22

    Tables

    • Figures
    • Table 1.

      Comparison of Diabetic Snack Bars*††

      Bars to Prevent Hypoglycemia
      Extend Bar** (Clinical Products, Ltd.)Nite Bite** Timed-Release Glucose Bar (ICN Pharmaceuticals, Inc.)Gluc-O-Bar** (APIC, USA, Inc.)
      Claims on product packageClinically proven to reduce episodes of low blood glucose for up to 9 h without causing high blood glucoseHelps prevent nighttime hypoglycemia; only glucose bar proven to be beneficial before exerciseNutritional bar that provides sustained glucose release over a prolonged interval without sudden peaks
      Description/use from product packageFor use before bedtime, exercise, or whenever low blood glucose is likely to occurIdeal before bed or exercise to help maintain blood glucose levelsDesigned for use day or night as part of the dietary management of abnormal blood glucose levels
      kcal160100130
      Carbohydrate (g)301521
      UCS (g)555
      Fiber (g)000
      Sugars (g)10 (fructose)10 (sucrose)1
      Sugar alcohol (g)5011
      Protein (g)2.537
      Fat (g)2.53.52.5
      Exchanges†2 starch1 starch, 0.5 fat1.5 starch

      Bars to Lessen Hyperglycemia
      Ensure Glucerna (Ross Products Division)Choice DM** (Mead Johnson Nutritionals)Choice DM** Crispy Bars* (Mead Johnson Nutritionals)
      Claims on product packageClinically shown to lower blood glucose response compared to an ordinary snack barClinically shown to cause less rise in blood glucose levels compared to snack bars testedDesigned to minimize postprandial peaks in blood glucose levels
      Description/use from product packageComplete, balanced nutrition specifically designed for people with diabetes. For use as a snack or occasional meal replacementNutritionally complete bars designed to help maintain blood glucose control; ideal as a snack between meals, after exercise, before bedtime, or anytime“Pick-me-up” snacks for people with diabetes designed to help manage blood glucose levels
      kcal140140120
      Carbohydrate (g)241921
      Resistant starches (g)4.83.21
      Fiber (g)431
      Sugars (g)795
      Sugar alcohol (g)567
      Protein (g)664
      Fat (g)44.52.5
      Exchanges†1.5 starch, 0.5 fat1 starch, 1 fat1.5 starch
      • *Nutrient data may vary slightly based on flavor.

      • **Peanut butter flavor used for comparison between brands; other flavors available.

      • †Exchange values as provided on product label.

      • ††All bars contain between 60 and 110 mg Na and 50 and 105 mg K per serving.

    PreviousNext
    Back to top

    In this Issue

    January 2001, 19(1)
    • Table of Contents
    • Index by Author
    Sign up to receive current issue alerts
    View Selected Citations (0)
    Print
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for your interest in spreading the word about Clinical Diabetes.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    The Science of Diabetic Snack Bars: A Review
    (Your Name) has forwarded a page to you from Clinical Diabetes
    (Your Name) thought you would like to see this page from the Clinical Diabetes web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    The Science of Diabetic Snack Bars: A Review
    Lisa E. Rafkin-Mervis, Jennifer B. Marks
    Clinical Diabetes Jan 2001, 19 (1) 4-12; DOI: 10.2337/diaclin.19.1.4

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Add to Selected Citations
    Share

    The Science of Diabetic Snack Bars: A Review
    Lisa E. Rafkin-Mervis, Jennifer B. Marks
    Clinical Diabetes Jan 2001, 19 (1) 4-12; DOI: 10.2337/diaclin.19.1.4
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • Abstract
      • The Use of Uncooked Cornstarch in Antihypoglycemia Bars
      • Background and Rationale for Using UCS
      • Why UCS Works
      • Studies of UCS
      • Diabetic Snack Bars Using UCS to Prevent Hypoglycemia
      • Diabetic Snack Bars Designed to Lessen Hyperglycemia
      • Clinical Implications
      • Footnotes
      • References
    • Figures & Tables
    • Info & Metrics
    • PDF

    Related Articles

    Cited By...

    More in this TOC Section

    • Opportunities and Challenges for Biosimilars: What's on the Horizon in the Global Insulin Market?
    • The Role of the Kidney and Sodium-Glucose Cotransporter-2 Inhibition in Diabetes Management
    • Tests for Screening and Diagnosis of Type 2 Diabetes
    Show more Features

    Similar Articles

    Navigate

    • Current Issue
    • Papers in Press
    • Abridged Standards of Care
    • Archives
    • Submit
    • Subscribe
    • Email Alerts
    • RSS Feeds

    More Information

    • About the Journal
    • Instructions for Authors
    • Journal Policies
    • Reprints and Permissions
    • Advertising
    • Privacy Policy: ADA Journals
    • Copyright Notice/Public Access Policy
    • Contact Us

    Other ADA Resources

    • Diabetes
    • Diabetes Care
    • Diabetes Spectrum
    • Scientific Sessions Abstracts
    • Standards of Medical Care in Diabetes
    • BMJ Open - Diabetes Research & Care
    • Professional Books
    • Diabetes Forecast

     

    • DiabetesJournals.org
    • Diabetes Core Update
    • ADA's DiabetesPro
    • ADA Member Directory
    • Diabetes.org

    © 2021 by the American Diabetes Association. Clinical Diabetes Print ISSN: 0891-8929, Online ISSN: 1945-4953.